Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin in Steroid-Refractory aGvHD
NCT00032773Phase 2Terminated
- Sponsor
- Astex Pharmaceuticals
- Start
- Jan 2002
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pentostatin in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Astex Pharmaceuticals. Started Jan 2002; status: terminated.
02
Drugs
pentostatin
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT00032773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032773.